Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Completed 115Recruiting 107Unknown 75Active not recruiting 52Not yet recruiting 41Withdrawn 18Terminated 16Suspended 3Enrolling by invitation 3Approved for marketing 2

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Hepatocellular 2Stomach Neoplasms 1Liver Neoplasms 1

Interventions

Cisplatin 9Specimen Handling 7Educational Status 7Standard of Care 6Interviews as Topic 6Drug Therapy 6Carboplatin 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Observation 4Lenalidomide 4Fluorouracil 4Dexamethasone 4pembrolizumab 3lenvatinib 3camrelizumab 3Surveys and Questionnaires 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Gemcitabine 3Fluorodeoxyglucose F18 3Exercise 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × lenvatinib × Clear all
NCT07356466 2026-01-21

FUGES032

Fujian Medical University

Phase EARLY_PHASE1 Enrolling by invitation
100 enrolled
Gastrointestinal

Stomach Neoplasms

NCT07052448 2025-07-04

The Efficacy of Sequential RT After Triple Therapy for uHCC

Fujian Provincial Hospital

Enrolling by invitation
35 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05171335 2022-09-21

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

The Methodist Hospital Research Institute

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡